Report overview
A psychiatric and nervous drug (psychiatric or psychotropic medication) is a psychoactive drug taken to exert an effect on the chemical makeup of the brain and nervous system.
Mental health and well-being affect our daily lives. Psychotropic medications can be an important part of the tools available to help keep us well.
This report contains market size and forecasts of Psychiatric and Nervous Drugs in global, including the following market information:
Global Psychiatric and Nervous Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Psychiatric and Nervous Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Psychiatric and Nervous Drugs companies in 2021 (%)
The global Psychiatric and Nervous Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antidepressants Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Psychiatric and Nervous Drugs include Pfizer, Ely Lilly, Actavis, Mylan, Randox, Intellipharmaceutics, Astrazeneca, Lundbeck and Allergan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Psychiatric and Nervous Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Psychiatric and Nervous Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Type, 2021 (%)
Antidepressants
Anti-anxiety
Antipsychotic
Mood Stabilizing
Stimulant Medications
Others
Global Psychiatric and Nervous Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Psychiatric and Nervous Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Psychiatric and Nervous Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Psychiatric and Nervous Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Psychiatric and Nervous Drugs revenues share in global market, 2021 (%)
Key companies Psychiatric and Nervous Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Psychiatric and Nervous Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Ely Lilly
Actavis
Mylan
Randox
Intellipharmaceutics
Astrazeneca
Lundbeck
Allergan
GSK
Otsuka Pharmaceutical
Takeda
NHU Group
Shionogi
APOTEX
Chengdu Kanghong Pharmaceutical
HUAHAI
Zhejiang Jianfeng
Beijing Winsunny Pharmaceutical
